Evidence map›Paper›PMID 34362433›Full record

ArticleNeural development2021

Neuronal Dystroglycan regulates postnatal development of CCK/cannabinoid receptor-1 interneurons.

Daniel S Miller, Kevin M Wright

Open access · goldAbstract read
In one paragraph

Article in Neural development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. UDP-glucose dehydrogenase variants cause dystroglycanopathy.Annals of clinical and translational neurology · 2025
    Article
  3. Article
  4. Alpha-neurexins in health and disease.Frontiers in molecular neuroscience · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Neurexins and their ligands at inhibitory synapses.Frontiers in synaptic neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel S MillerNeuroscience Graduate Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Kevin M WrightVollum Institute, Oregon Health & Science University, VIB 3435A, 3181 SW Sam Jackson Park Road, L474, Portland, OR, 97239-3098, USA. wrighke@ohsu.edu.ORCID 0000-0001-5094-5270
Oregon Health & Science University · US

Funding

Ultrastructure and Single Particle Microscopy CoreP30NS061800 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A · 2009 to 2020
$6.6M
The role of dystroglycan in neural circuit development.R01NS091027 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI WRIGHT, KEVIN · 2016 to 2020
$1.9M
Mechanism of dystroglycan function at inhibitory synapses.F31NS108522 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MILLER, DANIEL SCOTT · 2019 to 2020
$90k
NINDS NIH HHS F31 NS108522NINDS NIH HHS P30 NS061800NINDS NIH HHS R01 NS091027
6 · The paper itself

Abstract

backgroundThe development of functional neural circuits requires the precise formation of synaptic connections between diverse neuronal populations. The molecular pathways that allow GABAergic interneuron subtypes in the mammalian brain to initially recognize their postsynaptic partners remain largely unknown. The transmembrane glycoprotein Dystroglycan is localized to inhibitory synapses in pyramidal neurons, where it is required for the proper function of CCK+ interneurons. However, the precise temporal requirement for Dystroglycan during inhibitory synapse development has not been examined.

methodsIn this study, we use NEX

resultsIn the absence of postsynaptic Dystroglycan in developing pyramidal neurons, presynaptic CCK+ interneurons fail to elaborate their axons and largely disappear from the cortex, hippocampus, amygdala, and olfactory bulb during the first two postnatal weeks. Other interneuron subtypes are unaffected, indicating that CCK+ interneurons are unique in their requirement for postsynaptic Dystroglycan. Dystroglycan does not appear to be required in adult pyramidal neurons to maintain CCK+ interneurons. Bax deletion did not rescue CCK+ interneurons in Dystroglycan mutants during development, suggesting that they are not eliminated by canonical apoptosis. Rather, we observed increased innervation of the striatum, suggesting that the few remaining CCK+ interneurons re-directed their axons to neighboring areas where Dystroglycan expression remained intact.

conclusionTogether these findings show that Dystroglycan functions as part of a synaptic partner recognition complex that is required early for CCK+ interneuron development in the forebrain.

Indexed as

DystroglycansInterneuronsAnimalsNeuronsPyramidal CellsReceptors, CannabinoidDystroglycansReceptors, CannabinoidApoptosisCannabinoid receptorCholecystokininDystroglycanInterneuronSynapse

Identifiers

PMID34362433
PMCPMC8349015
OpenAlexW3190959969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.